Tunstall, the market leading provider of technology enabled care services, announces that Gordon Sutherland has been appointed as its new Chief Executive Officer, succeeding Paul Stobart.

Mr Sutherland has 35 years’ experience in the healthcare industry, holding a number of key executive leadership roles. Most recently he was Head of the EMEA businesses of Invacare Corporation, a NYSE listed company in the medical equipment industry. Prior to Invacare Gordon has worked at Gambro AB, Baxter Healthcare Corporation, Bristol-Myers Squibb and Johnson & Johnson.

Malcolm Miller, Chairman, commented:

“I am delighted to welcome Gordon Sutherland to Tunstall. We will benefit greatly from the depth of his healthcare industry experience as we embark on the next phase of our journey, to cement our leadership position in technology enabled care. On behalf of the Board I would like to thank Paul Stobart for his work in repositioning the Group over the last three years, setting foundations for our future success.”

Gordon Sutherland commented:

“Tunstall is a business with a rich history and strong track record. I am looking forward to leading the organisation and ensuring the business continues its record of innovation, providing re-assurance to our customers and value for our shareholders.”